PR013

· Realm Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PR013, covering 2020-01-29 to 2020-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis [Phase 2]

See pricing